Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1260098.RAlLsqXN7Cav3TTZ1rN9Ln8UzgURu_myPm5ZttYMm-LBg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1260098.RAlLsqXN7Cav3TTZ1rN9Ln8UzgURu_myPm5ZttYMm-LBg130_assertion type Assertion NP1260098.RAlLsqXN7Cav3TTZ1rN9Ln8UzgURu_myPm5ZttYMm-LBg130_head.
- NP1260098.RAlLsqXN7Cav3TTZ1rN9Ln8UzgURu_myPm5ZttYMm-LBg130_assertion description "[Further studies indicated that the HGF/MET signaling pathway was involved in in vitro motility and invasion activities of the G3H cells and treatments with MET inhibitors decreased formation of distant metastases in our orthotopic model using G3H cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1260098.RAlLsqXN7Cav3TTZ1rN9Ln8UzgURu_myPm5ZttYMm-LBg130_provenance.
- NP1260098.RAlLsqXN7Cav3TTZ1rN9Ln8UzgURu_myPm5ZttYMm-LBg130_assertion evidence source_evidence_literature NP1260098.RAlLsqXN7Cav3TTZ1rN9Ln8UzgURu_myPm5ZttYMm-LBg130_provenance.
- NP1260098.RAlLsqXN7Cav3TTZ1rN9Ln8UzgURu_myPm5ZttYMm-LBg130_assertion SIO_000772 25640943 NP1260098.RAlLsqXN7Cav3TTZ1rN9Ln8UzgURu_myPm5ZttYMm-LBg130_provenance.
- NP1260098.RAlLsqXN7Cav3TTZ1rN9Ln8UzgURu_myPm5ZttYMm-LBg130_assertion wasDerivedFrom befree-2016 NP1260098.RAlLsqXN7Cav3TTZ1rN9Ln8UzgURu_myPm5ZttYMm-LBg130_provenance.
- NP1260098.RAlLsqXN7Cav3TTZ1rN9Ln8UzgURu_myPm5ZttYMm-LBg130_assertion wasGeneratedBy ECO_0000203 NP1260098.RAlLsqXN7Cav3TTZ1rN9Ln8UzgURu_myPm5ZttYMm-LBg130_provenance.